Clinical Trial Update: Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating immediate-release ropinirole for restless legs syndrome in patients with chronic kidney disease on haemodialysis; study termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• ropinirole IR (Immediate Release) tablets (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Restless Legs Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2011-06-13